Adalimumab sustains clinical remission and overall clinical benefit after 2 years of therapy for Crohn's disease (Q42653303)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Adalimumab sustains clinical remission and overall clinical benefit after 2 years of therapy for Crohn's disease |
scientific article |
Statements
1 reference
Adalimumab sustains clinical remission and overall clinical benefit after 2 years of therapy for Crohn's disease (English)
1 reference
W J Sandborn
1 reference
P Rutgeerts
1 reference
J-F Colombel
1 reference
G R D'Haens
1 reference
R Panaccione
1 reference
A M Robinson
1 reference
J Chao
1 reference
P M Mulani
1 reference
P F Pollack
1 reference
18 March 2010
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference